Relafen 750, or unique preparation of naproxen, offers the compelling study from a biochemical pharmacy view. Its mechanism of action, essentially involving suppression of cyclooxygenase enzymes namely COX-1 and COX-2 – leads to significant decrease in prostaglandin synthesis. Within our biochemical framework, the drug's effectiveness is closely